trial · primary record
ABP-671 plus allopurinol
Gout Chronic
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 22 |
| Primary completion | 2026-08-19 |
| Primary endpoint | Maximum plasma concentration (Cmax) of allopurinol |
| Registry ID | NCT07367971 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:09.878Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07367971
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.